An older woman developed acute progressive limb weakness associated with pain, paraesthesia and falls 2 weeks after receiving a respiratory syncytial virus (RSV) vaccine. Initial examination and imaging suggested alternative diagnoses, including cervical spondylotic disease and cerebrovascular pathology and early neurophysiology was non-diagnostic. During admission, she deteriorated with urinary retention, areflexia and type 2 respiratory failure requiring intubation and ventilation and was commenced on intravenous immunoglobulin (IVIG). Cerebrospinal fluid analysis later demonstrated albumin-cytologic dissociation and repeat nerve conduction studies confirmed an acute inflammatory demyelinating polyradiculoneuropathy consistent with Guillain-Barré syndrome (GBS). She improved following intensive care and IVIG, with partial recovery of limb strength and functional status and was discharged to a rehabilitation facility. This case illustrates a rare but important possible association between RSV vaccination and GBS; highlights the diagnostic challenges of early presentations with non-specific symptoms and inconclusive investigations; and emphasises the need for serial assessment and early escalation of care to optimise patient outcomes.
No takes yet. Share an insight, caveat, or question.
Hreiz et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: